Celularity Inc

CELUNASDAQ · Pharmaceutical Preparations

Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

32.4M

on 2026-09-24, from 21.8M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$10.0M

Agreement of 2024-03-13. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

25.77M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

0.2 quarters

$368K on 2026-03-31 ÷ $2.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-07-14	Private placement	not read	$1.625	$2.0M	8-K ↗
2025-06-23	Private placement	not read	$1.40	$1.0M	8-K ↗

Also on file: $6.0M notes, 2025-02-12 8-K ↗ · $6.8M promissory note, 2025-07-21 8-K ↗ · $8.4M convertible notes, 2025-12-22 8-K ↗ · $25.0M convertible notes, 2026-09-23 8-K ↗ · a going-concern note in the 10-Q filed 2026-09-29 10-Q ↗